Relapsed/refractory marginal zone lymphoma (r/r mzl) Clinical Trials
Conditions / Relapsed/refractory marginal zone lymphoma (r/r mzl)
Delta Trials catalogs 1 clinical trial for Relapsed/refractory marginal zone lymphoma (r/r mzl) in its publicly accessible dataset. Within this set, 1 currently recruiting participants and 0 trials have reached completion. This research occurs across 141 participating sites around the world. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
1
Total Trials
1
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
141
Study Locations
Browse by location (141 total)
- Waratah, Australia 1 trialAll trials in Waratah, Australia
- Roeselare, Belgium 1 trialAll trials in Roeselare, Belgium
- Hradec Králové, Czechia 1 trialAll trials in Hradec Králové, Czechia
- Rouen, France 1 trialAll trials in Rouen, France
- Salisbury, United Kingdom 1 trialAll trials in Salisbury, United Kingdom
- Barcelona, Spain 1 trialAll trials in Barcelona, Spain
- Vienna, Austria 1 trialAll trials in Vienna, Austria
- Cascavel, Brazil 1 trialAll trials in Cascavel, Brazil
- Brasília, Brazil 1 trialAll trials in Brasília, Brazil
- Wrocław, Poland 1 trialAll trials in Wrocław, Poland
- Yenimahalle, Turkey (türkiye) 1 trialAll trials in Yenimahalle, Turkey (türkiye)
- Kota Kinabalu, Malaysia 1 trialAll trials in Kota Kinabalu, Malaysia
- Changhua, Taiwan 1 trialAll trials in Changhua, Taiwan
- Liverpool, Australia 1 trialAll trials in Liverpool, Australia
- Naples, Italy 1 trialAll trials in Naples, Italy
- Izmir, Turkey (türkiye) 1 trialAll trials in Izmir, Turkey (türkiye)
- Pavia, Italy 1 trialAll trials in Pavia, Italy
- Nahariya, Israel 1 trialAll trials in Nahariya, Israel
- Novara, Italy 1 trialAll trials in Novara, Italy
- Hattiesburg, United States 1 trialAll trials in Hattiesburg, United States